Mackenzie Financial Corp Ocular Therapeutix, Inc Transaction History

Mackenzie Financial Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2023 Aug 03, 2023	SELL	$4.6 - $7.64 $100,279 - $166,552	-21,800 Reduced 33.04%	44,173 $227,000
Q1 2023 Apr 24, 2023	BUY	$2.79 - $6.27 $184,064 - $413,650	65,973 New	65,973 $347,000

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.